Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Friess

Showing results (611-620 of 770) with videos related to

Pageof 77
Sort By:
Hepatology (Baltimore, Md.)|February 21, 2013
Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cellsMartin Franz Sprinzl, Florian Reisinger, Andreas Puschnik, et al.
Gut|March 18, 2019
Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based studyEnrico N De Toni, Anne Schlesinger-Raab, Martin Fuchs, et al.
Annals of Surgery|July 21, 2023
Goal-directed Perioperative Albumin Substitution Versus Standard of Care to Reduce Postoperative Complications: A Randomized Clinical Trial (SuperAdd Trial)Stefan J Schaller, Kristina Fuest, Bernhard Ulm, et al.
Molecular Cancer|December 20, 2015
Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinomaBo Kong, Tao Cheng, Chengjia Qian, et al.
BMC Cancer|May 28, 2009
A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2Angela Märten, Jan Schmidt, Jennifer Ose, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2007
Transcriptional network governing the angiogenic switch in human pancreatic cancerAmir Abdollahi, Christian Schwager, Jörg Kleeff, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 20, 2026
Myeloid ATF3 Protects Against Liver Fibrosis by Modulating the Extracellular Microenvironment and Macrophage Inflammatory SignalingHao Ling, Yanzhu Hu, Janset Onyuru, et al.
Gland Surgery|March 4, 2022
Impact of pylorus preservation on delayed gastric emptying after pancreaticoduodenectomy-analysis of 5,000 patients based on the German StuDoQ|Pancreas-RegistryTim Fahlbusch, Andreas Minh Luu, Philipp Höhn, et al.
Frontiers in Oncology|July 3, 2020
ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose MetabolismShuang Nie, Xuetian Qian, Mengyue Shi, et al.
BJS Open|January 25, 2024
Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective studyRuediger Goess, Carsten Jäger, Julie Perinel, et al.
Pageof 77

Showing results (611-620 of 770) with videos related to

Sort By:
Pageof 77
Hepatology (Baltimore, Md.)|February 21, 2013
Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cellsMartin Franz Sprinzl, Florian Reisinger, Andreas Puschnik, et al.
Gut|March 18, 2019
Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based studyEnrico N De Toni, Anne Schlesinger-Raab, Martin Fuchs, et al.
Annals of Surgery|July 21, 2023
Goal-directed Perioperative Albumin Substitution Versus Standard of Care to Reduce Postoperative Complications: A Randomized Clinical Trial (SuperAdd Trial)Stefan J Schaller, Kristina Fuest, Bernhard Ulm, et al.
Molecular Cancer|December 20, 2015
Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinomaBo Kong, Tao Cheng, Chengjia Qian, et al.
BMC Cancer|May 28, 2009
A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2Angela Märten, Jan Schmidt, Jennifer Ose, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2007
Transcriptional network governing the angiogenic switch in human pancreatic cancerAmir Abdollahi, Christian Schwager, Jörg Kleeff, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 20, 2026
Myeloid ATF3 Protects Against Liver Fibrosis by Modulating the Extracellular Microenvironment and Macrophage Inflammatory SignalingHao Ling, Yanzhu Hu, Janset Onyuru, et al.
Gland Surgery|March 4, 2022
Impact of pylorus preservation on delayed gastric emptying after pancreaticoduodenectomy-analysis of 5,000 patients based on the German StuDoQ|Pancreas-RegistryTim Fahlbusch, Andreas Minh Luu, Philipp Höhn, et al.
Frontiers in Oncology|July 3, 2020
ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose MetabolismShuang Nie, Xuetian Qian, Mengyue Shi, et al.
BJS Open|January 25, 2024
Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective studyRuediger Goess, Carsten Jäger, Julie Perinel, et al.
Pageof 77